Medical Education Library

Highlights From the 7th Joint ECTRIMS‑ACTRIMS Meeting

Publish date: November 20, 2017

Neurology Reviews presents selected news highlights from the 7th Joint ECTRIMS‑ACTRIMS Meeting.

 

Recommended Reading

Oligoclonal Bands Could Be a Valuable Criterion for the Diagnosis of MS
MDedge Neurology
DMTs Reduce the Risk of Conversion to Secondary Progressive MS
MDedge Neurology
The Diagnostic Value of 2010 McDonald Criteria Versus 2016 MAGNIMS Guidelines for Special MS Populations
MDedge Neurology
The Expanded Timed Get Up and Go Test Predicts MS Disability
MDedge Neurology
Long-Term Outcomes of Neuromyelitis Optica
MDedge Neurology
What Is the Prevalence of Truly Benign MS?
MDedge Neurology
How Does Cladribine Compare With Other MS Therapies?
MDedge Neurology
Which Factors Predict Conversion From CIS to MS?
MDedge Neurology
Durable Improvements in Clinical Outcomes With Alemtuzumab: Seven-Year Follow-Up
MDedge Neurology
MS Treatment Decisions Based on Milestones That Matter
MDedge Neurology